Fonte: International journal of oncology. Unidade: FM
Assuntos: DNA, RNA, NEOPLASIAS MAMÁRIAS (GENÉTICA), LEUCEMIA, METÁSTASE NEOPLÁSICA, GENES, EXPRESSÃO GÊNICA, GENOMAS
ABNT
SANTOS, Emerson de Souza et al. Silencing of LRRC49 and THAP10 genes by bidirectional promoter hypermethylation is a frequent event in breast cancer. International journal of oncology, v. 33, n. 1, p. 25-31, 2008Tradução . . Disponível em: https://doi.org/10.3892/ijo.33.1.25. Acesso em: 30 set. 2024.APA
Santos, E. de S., Bessa, S. A. de, Netto, M. M., & Nagai, M. A. (2008). Silencing of LRRC49 and THAP10 genes by bidirectional promoter hypermethylation is a frequent event in breast cancer. International journal of oncology, 33( 1), 25-31. doi:10.3892/ijo.33.1.25NLM
Santos E de S, Bessa SA de, Netto MM, Nagai MA. Silencing of LRRC49 and THAP10 genes by bidirectional promoter hypermethylation is a frequent event in breast cancer [Internet]. International journal of oncology. 2008 ; 33( 1): 25-31.[citado 2024 set. 30 ] Available from: https://doi.org/10.3892/ijo.33.1.25Vancouver
Santos E de S, Bessa SA de, Netto MM, Nagai MA. Silencing of LRRC49 and THAP10 genes by bidirectional promoter hypermethylation is a frequent event in breast cancer [Internet]. International journal of oncology. 2008 ; 33( 1): 25-31.[citado 2024 set. 30 ] Available from: https://doi.org/10.3892/ijo.33.1.25